S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
Dems' climate, energy, tax bill clears initial Senate hurdle
Democrats hit roadblock, but push Biden package in Senate
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
Dems' climate, energy, tax bill clears initial Senate hurdle
Democrats hit roadblock, but push Biden package in Senate
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
Dems' climate, energy, tax bill clears initial Senate hurdle
Democrats hit roadblock, but push Biden package in Senate
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Shift in war's front seen as ships cleared to leave Ukraine
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
Dems' climate, energy, tax bill clears initial Senate hurdle
Democrats hit roadblock, but push Biden package in Senate
Followed 141 Times  
NYSE:TDOC

Teladoc Health - TDOC Stock Forecast, Price & News

$37.48
+0.02 (+0.05%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$35.19
▼
$37.53
50-Day Range
$28.63
▼
$43.66
52-Week Range
$27.38
▼
$156.82
Volume
4.59 million shs
Average Volume
5.80 million shs
Market Capitalization
$6.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$67.97

Teladoc Health MarketRank™ Forecast

Analyst Rating
Hold
2.15 Rating Score
Upside/​Downside
81.3% Upside
$67.97 Price Target
Short Interest
Healthy
20.66% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.23mentions of Teladoc Health in the last 14 days
Based on 42 Articles This Week
Insider Trading
Selling Shares
$221,498 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.64) to ($1.29) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.59 out of 5 stars

Medical Sector

124th out of 1,283 stocks

Offices & Clinics Of Medical Doctors Industry

1st out of 9 stocks

See Top Rated MarketRank™ Stocks Here
TDOC stock logo

About Teladoc Health (NYSE:TDOC) Stock

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on TDOC shares. Cowen downgraded Teladoc Health from an "outperform" rating to a "market perform" rating and reduced their price target for the stock from $58.00 to $34.00 in a report on Tuesday, August 2nd. Stifel Nicolaus reduced their price target on Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th. SVB Leerink reduced their price target on Teladoc Health from $35.00 to $34.00 and set a "market perform" rating on the stock in a report on Thursday, July 28th. Piper Sandler reduced their price target on Teladoc Health from $42.00 to $40.00 and set an "overweight" rating on the stock in a report on Thursday, July 28th. Finally, Canaccord Genuity Group reduced their price target on Teladoc Health from $50.00 to $45.00 in a report on Thursday, July 28th. One research analyst has rated the stock with a sell rating, twenty-three have issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Teladoc Health currently has a consensus rating of "Hold" and a consensus target price of $71.03.

Teladoc Health Trading Up 0.1 %

Shares of TDOC traded up $0.02 during mid-day trading on Friday, hitting $37.48. 4,593,541 shares of the company traded hands, compared to its average volume of 5,802,551. Teladoc Health has a 1-year low of $27.38 and a 1-year high of $156.82. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.71 and a current ratio of 3.94. The business has a 50 day moving average of $36.47 and a 200 day moving average of $51.71.

Insider Activity

In other news, SVP Daniel Trencher sold 1,000 shares of the company's stock in a transaction dated Friday, June 17th. The shares were sold at an average price of $29.12, for a total transaction of $29,120.00. Following the transaction, the senior vice president now owns 28,408 shares in the company, valued at $827,240.96. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CFO Mala Murthy sold 4,053 shares of the stock in a transaction that occurred on Monday, June 27th. The shares were sold at an average price of $37.32, for a total value of $151,257.96. Following the transaction, the chief financial officer now owns 27,295 shares in the company, valued at approximately $1,018,649.40. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Friday, June 17th. The stock was sold at an average price of $29.12, for a total transaction of $29,120.00. Following the completion of the transaction, the senior vice president now owns 28,408 shares in the company, valued at approximately $827,240.96. The disclosure for this sale can be found here. Insiders have sold a total of 6,053 shares of company stock worth $221,498 over the last 90 days. 1.55% of the stock is currently owned by corporate insiders.

Receive TDOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

TDOC Stock News Headlines

August 6, 2022 | finance.yahoo.com
Is There any Hope for Teladoc Stock in 2023?
August 5, 2022 | finance.yahoo.com
Can This Beaten-Down Stock Make a Comeback?
August 7, 2022 | RJO Futures (Ad)
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile. Take your trading to the next level with the Options Strategy Guide. pixel
August 5, 2022 | finance.yahoo.com
Why Selling Teladoc Right Now Could Be a Huge Mistake
August 5, 2022 | americanbankingnews.com
Cowen Lowers Teladoc Health (NYSE:TDOC) to Market Perform
August 5, 2022 | americanbankingnews.com
Teladoc Health (NYSE:TDOC) Cut to Market Perform at Cowen
August 5, 2022 | americanbankingnews.com
Teladoc Health, Inc. (NYSE:TDOC) Expected to Post Q3 2022 Earnings of ($0.64) Per Share
August 4, 2022 | benzinga.com
CLASS ACTION UPDATE for TDOC, YEXT and WEBR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
August 7, 2022 | RJO Futures (Ad)
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile. Take your trading to the next level with the Options Strategy Guide. pixel
August 4, 2022 | apnews.com
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Teladoc Health, Inc. (TDOC)
August 4, 2022 | nasdaq.com
TDOC September 23rd Options Begin Trading
August 3, 2022 | finance.yahoo.com
Here is What to Know Beyond Why Teladoc Health, Inc. (TDOC) is a Trending Stock
August 3, 2022 | finance.yahoo.com
1 Growth Stock Down 76% to Buy and Hold
August 3, 2022 | americanbankingnews.com
Teladoc Health (NYSE:TDOC) Lowered to Hold at Berenberg Bank
August 3, 2022 | benzinga.com
LAWSUITS FILED AGAINST TDOC, YEXT and U
August 3, 2022 | nasdaq.com
Teladoc Stock: Unhealthy Net Loss Means More Downside is Probable
August 3, 2022 | americanbankingnews.com
SVB Leerink Weighs in on Teladoc Health, Inc.'s Q3 2022 Earnings (NYSE:TDOC)
August 2, 2022 | seekingalpha.com
Teladoc downgraded at Cowen, Berenberg on macro headwinds, 'underwhelming execution'
August 2, 2022 | apnews.com
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Teladoc Health, Inc. – TDOC
August 2, 2022 | americanbankingnews.com
Teladoc Health (NYSE:TDOC) PT Lowered to $34.00
August 2, 2022 | americanbankingnews.com
StockNews.com Upgrades Teladoc Health (NYSE:TDOC) to Sell
August 2, 2022 | americanbankingnews.com
Brokers Set Expectations for Teladoc Health, Inc.'s Q3 2022 Earnings (NYSE:TDOC)
August 1, 2022 | americanbankingnews.com
Piper Sandler Lowers Teladoc Health (NYSE:TDOC) Price Target to $40.00
July 31, 2022 | americanbankingnews.com
Oppenheimer Trims Teladoc Health (NYSE:TDOC) Target Price to $55.00
July 31, 2022 | americanbankingnews.com
Teladoc Health (NYSE:TDOC) Price Target Cut to $45.00
July 31, 2022 | americanbankingnews.com
Teladoc Health (NYSE:TDOC) Price Target Cut to $34.00 by Analysts at SVB Leerink
July 31, 2022 | americanbankingnews.com
Teladoc Health (NYSE:TDOC) Cut to Neutral at The Goldman Sachs Group
See More Headlines
Receive TDOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

TDOC Company Calendar

Last Earnings
10/27/2021
Today
8/07/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:TDOC
CUSIP
N/A
CIK
1477449
Web
www.teladochealth.com
Phone
(203) 635-2002
Fax
N/A
Employees
5,100
Year Founded
2002

Price Target and Rating

Average Stock Price Forecast
$67.97
High Stock Price Forecast
$210.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+81.3%
Consensus Rating
Hold
Rating Score (0-4)
2.15
Research Coverage
27 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($61.40)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-428,790,000.00
Net Margins
-441.94%
Pretax Margin
-323.92%
Return on Equity
-1.76%
Return on Assets
-1.56%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
3.94
Quick Ratio
3.71

Sales & Book Value

Annual Sales
$2.03 billion
Price / Sales
2.97
Cash Flow
$0.44 per share
Price / Cash Flow
84.26
Book Value
$100.23 per share
Price / Book
0.37

Miscellaneous

Outstanding Shares
161,180,000
Free Float
158,685,000
Market Cap
$6.04 billion
Optionable
Optionable
Beta
0.82

Social Links


Key Executives

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













TDOC Stock - Frequently Asked Questions

Should I buy or sell Teladoc Health stock right now?

27 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last twelve months. There are currently 23 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Teladoc Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TDOC, but not buy additional shares or sell existing shares.
View analyst ratings for Teladoc Health or view top-rated stocks.

What is Teladoc Health's stock price forecast for 2022?

27 Wall Street research analysts have issued 12 month target prices for Teladoc Health's stock. Their TDOC stock forecasts range from $30.00 to $210.00. On average, they anticipate Teladoc Health's stock price to reach $67.97 in the next twelve months. This suggests a possible upside of 81.3% from the stock's current price.
View analysts' price targets for Teladoc Health or view top-rated stocks among Wall Street analysts.

How has Teladoc Health's stock price performed in 2022?

Teladoc Health's stock was trading at $91.82 on January 1st, 2022. Since then, TDOC stock has decreased by 59.2% and is now trading at $37.48.
View the best growth stocks for 2022 here.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our earnings forecast for Teladoc Health.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) released its quarterly earnings results on Wednesday, October, 27th. The health services provider reported ($0.53) earnings per share for the quarter, beating analysts' consensus estimates of ($0.70) by $0.17. The health services provider had revenue of $521.70 million for the quarter, compared to the consensus estimate of $516.79 million. Teladoc Health had a negative trailing twelve-month return on equity of 1.76% and a negative net margin of 441.94%. The firm's revenue was up 80.6% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.13) EPS.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health updated its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of -$0.85--$0.60 for the period, compared to the consensus EPS estimate of -$0.55. The company issued revenue guidance of $600.00 million-$620.00 million, compared to the consensus revenue estimate of $613.73 million.

What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health CEO Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among Teladoc Health's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Block (SQ), Shopify (SHOP), DocuSign (DOCU), Salesforce (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (5.41%), Nikko Asset Management Americas Inc. (5.14%), Connor Clark & Lunn Investment Management Ltd. (0.22%), DekaBank Deutsche Girozentrale (0.18%), State Board of Administration of Florida Retirement System (0.12%) and AMF Tjanstepension AB (0.10%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David Travers, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Sandra L Fenwick, Stephany Verstraete, William H Frist and Yulun Wang.
View institutional ownership trends for Teladoc Health.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $37.48.

How much money does Teladoc Health make?

Teladoc Health (NYSE:TDOC) has a market capitalization of $6.04 billion and generates $2.03 billion in revenue each year. The health services provider earns $-428,790,000.00 in net income (profit) each year or ($61.40) on an earnings per share basis.

How many employees does Teladoc Health have?

Teladoc Health employs 5,100 workers across the globe.

Does Teladoc Health have any subsidiaries?

The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..
Read More

When was Teladoc Health founded?

Teladoc Health was founded in 2002.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The official website for Teladoc Health is www.teladochealth.com. The health services provider can be reached via phone at (203) 635-2002 or via email at teladoc@westwicke.com.

This page (NYSE:TDOC) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.